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Abstract
Introduction In adult patients, most inguinal hernias are
treated by implanting a prosthetic mesh. To prevent mesh
dislocation and thus recurrence, different types of ﬁxation
have been proposed. In contrast to penetrating ﬁxation
known to cause acute chronic pain, adhesive ﬁxation is
becoming increasingly popular as it reduces markedly the
risk of injury and chronic pain. Apart from the biological
sealants (e.g., ﬁbrin glue), surgical adhesives include a
group of synthetic glues and genetically engineered protein
glues. For example, cyanoacrylate is used in various
medical and veterinary indications due to its fast action,
excellent bonding strength and low price.
Objective The main objective of this paper was to com-
municate positive results obtained using n-butyl-cyanoac-
rylate glue to ﬁx prosthetic meshes in over 1,300 TAPP
repairs of primary and recurrent inguinal hernias. The
secondary objective was to highlight the rationale (e.g.,
safety) for using non-ﬁbrin based glue in this type of
procedure.
Method We present the in vitro and in vivo data neces-
sary for the approval of n-butyl cyanoacrylate Histoacryl

glue. We use an equivalent glue, Glubran-2
, to ﬁx pros-
thetic meshes in 1,336 laparoscopic TAPP repairs.
Results Standardized tests to detect sensitization, irrita-
tion, genotoxicity or systemic toxicity demonstrated the
safety and biocompatibility of Histoacryl
, which met all
requirements, including those of ISO 10993. Histological
long-term studies in rabbits yielded results comparable to
routine suture ﬁxations, with full integration of the mesh
into the abdominal wall. The clinical results showed the
following advantages: fast application of the glue, reduced
postoperative pain, 0.0% infection rate, continuously low
recurrence rate and shorter hospital stay. No adverse effects
and no complaints were recorded.
Conclusion The experimental and clinical data demon-
strate the safe use and the excellent cost-beneﬁt ratio of
n-butyl cyanoacrylate compared with other techniques of
mesh ﬁxation.
Keywords Laparoscopic hernia repair  Mesh ﬁxation 
Glue ﬁxation  Cyanoacrylate
Introduction
Scientiﬁc background
Cyanoacrylate is the generic name of a group of fast-acting
adhesives such as ethyl-2-cyanoacrylate, n-butyl cyanoac-
rylate, 2-octyl cyanoacrylate sold under various trade
names like Histoacryl
, Indermil
, Dermabond
 or Glu-
bran
. Cyanoacrylate is an acrylic resin that polymerizes
exothermically in the presence of water, especially with
hydroxide ions, joining the bonded surfaces in 5–6 s and
reaching the ﬁnal stage in 60 s. It bonds body tissue
excellently and shows bacteriostatic effects. The ﬁlm of
glue is eliminated by hydrolytic breakdown, a process
whose duration varies according to tissue type and quantity
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sutureless surgery since the early 1970s. n-Butyl cyano-
acrylate, known as Enbucrilate, is a butylester of 2-cyano-
2-propenoic acid.
In medical and veterinary applications, n-butyl- and
octyl-cyanoacrylate are used commonly and in general do
not cause pain. Butyl esters provide stronger but more rigid
bonds, octyl esters weaker but more ﬂexible bonds, with
much slower degradation due to the longer side chain.
Since the 1970s, butyl cyanoacrylate has been used as a
medical adhesive, or as hemostatic or embolic agent to
repair lacerations, to close the skin in pediatric surgery, to
obliterate the processus vaginalis in congenital inguinal
hernias, to control hemostasis of parenchymal organs, to
perform aortic and thoracic surgery, to treat arteriovenous
malformations, or bleeding gastric varices, and to carry
out interventional radiology and vascular neuroradiology
[1–4].
Clinical background
Preamble
The recurrence rate of preperitoneal mesh hernia repair
would approach zero if a correctly implanted mesh
remained in place.
Since the introduction of prosthetic meshes in the 1960s,
a major concern has been to prevent dislocation of the
mesh before it is incorporated and stabilized in its original
position.
Renee Stoppa—one of the pioneers of modern herniol-
ogy—has demonstrated in his GPRVS (giant prosthetic
reinforcement of the visceral sac) that a large prosthetic
mesh placed in the preperitoneal space reduced the risk of
recurrence even without excessive ﬁxation [5]. Intra-
abdominal pressure helps to keep the mesh in place until it
is deﬁnitively ﬁxed by scar tissue.
In the early 1990s, laparo-endoscopic surgeons started
imitating the successful Stoppa procedure in the form of
TEP and TAPP. However, they found the extent of dis-
section of the preperitoneal space recommended by Stoppa
to be too large, so they reduced the dissection and used
smaller meshes but stronger ﬁxation. Nevertheless, they
could not prevent mesh dislocation being one of the most
frequent causes of recurrence. Various tacking devices,
staplers and suturing techniques were developed to over-
come this problem. During the same period, two new
anatomic areas of the groin were delineated: the triangle of
doom and the triangle of pain. The vulnerable structures in
these anatomic areas made penetrating ﬁxation hazardous
due to the risk of vascular injury or chronic pain. Yet the
non-ﬁxed lateral lower mesh quadrant was obviously prone
to dislocation. Thus, the surgeons began using bigger
(or wider) meshes, without cutting them, and ﬁxing them
with adhesives [6–10].
In 2001, Katkhouda et al. [11] proposed to use ﬁbrin
sealants to ﬁx the mesh. Several experienced surgeons or
specialized centers went even further, they used bigger
meshes and did not ﬁx them at all [12–19]. Some investi-
gators observed a marked increase in recurrence [20], but
others noted only a slight increase, especially since the
introduction of the light meshes [21].
After a decade attempting to cope with recurrence, the
present decade must address chronic pain. Although the
pain scores after laparoscopic repairs are lower than after
open repair [22, 23], the penetrating ﬁxation used may
cause acute or chronic pain and increases both direct and
indirect costs. In their randomized study, Koch et al. [24]
conclude that elimination of tack ﬁxation reduces signiﬁ-
cantly the need for postoperative narcotic analgesia, hos-
pital stay and postoperative urinary retention.
Lovisetto [25] reports lower incidence of postoperative
neuralgia and earlier resumption of physical and social
activities when comparing ﬁbrin glue with staple ﬁxation in
TAPP repair.
Since2001,topreventbothrecurrenceandinjurycausing
chronic pain, one of the authors (J.F.K.) started routinely
using a glue to ﬁx meshes. In contrast to most cyanoacrylate
glues used forexternal applications like skin woundclosure,
the glue used, ‘‘Glubran-2
’’, a n-butyl-cyanoacrylate, is
CE-certiﬁed for both external and internal use.
The following experimental and clinical evidence has
been provided for the safe use of n-butyl cyanoacrylate
(nBCA) in this context.
Materials and methods
Experimental approach
Biocompatibility testing
Any implant that remains in the body for more than 30 days
must be subjected to tests described in the ISO 10993 Stan-
dard [26] for approval as a medical device. These tests
include assessment of cytotoxicity, sensitization, irritation,
systemic toxicity, genotoxicity and implantation.
For the assessment of cytotoxicity, L929 mouse ﬁbro-
blasts were incubated for 48 h at 37C with an extract of
Histoacryl
 in 1XMEM (single strength minimum essen-
tial medium supplemented with 5% serum and 2% antibi-
otics). Changes in cell morphology were examined
microscopically. The original extraction medium served as
a control, a sample of tin-stabilized polyvinylchloride as a
positive control, and a sample of high density polyethylene
as a negative control.
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Histoacryl
 with 0.9% sodium chloride and with sesame
oil [27]. Each extract was injected intradermally and pat-
ched occlusively to ten guinea pigs to induce sensitization.
A second induction followed 7 days later. After a recovery
period of 14 days, a challenge patch of the extract was
applied. The dermal reaction was recorded 24 and 48 h
after patch removal and compared to the dermal reaction
induced by the original extraction medium using the same
procedure.
Histoacryl
 extracts with 0.9% sodium chloride and
with sesame oil were injected into rabbits to test for irri-
tation and delayed-type hypersensitivity. The skin reaction
was examined immediately after injection and after 24, 48
and 72 h for erythema or oedema compared to the injection
site of the original sodium chloride solution or sesame oil.
Systemic toxicity was evaluated by intravenous and
intraperitoneal injection of a 0.9% sodium chloride or
sesame oil extract of Histoacryl
 to ﬁve mice. As control,
ﬁve mice were treated with the original extraction medium.
All animals were observed for signs of systemic toxicity
immediately after injection and at 4, 24, 48 und 72 h post-
injection.
Genotoxicity was assessed by the Ames test (a bacterial
reverse mutation test) performed according to the OECD
guidelines: Test No. 471 [28]. In summary, the ability of
Histoacryl
 extracts in a 95% ethanol solution or a 0.9%
sodium chloride solution to induce reverse mutations was
evaluated either in the presence or absence of mammalian
microsomal enzymes at the histidine locus of ﬁve strains of
Salomella typhimurium, or the tryptophan locus of Esche-
richia coli. Molten top agar was supplemented with histi-
dine-biotin or tryptophan for S. typhimurium or E. coli
strains, respectively. This addition allowed the bacteria on
the plate to undergo several divisions to produce a faint
background lawn, which was examined under a darkﬁeld
colony counter.
The original extraction medium was used as negative
control, and sodium azide, methyl methanesulfonate,
2-aminoanthracene, benzo[a]pyrene and 2-nitroﬂuorene
and acridine mutagen ICR-191 as positive control.
Animal study
The study was carried out on 48 female SPFalbino rabbits
[Chbb:HM(SPF)-Kleinrusse], weighing 2,100–3,300 g,
from Charles River Deutschland (Kisslegg, Germany),
according to the requirements of the OECD ‘‘Good labora-
tory practice’’ guidelines (GLP). The animals were allowed
5 daystoacclimate,andwerekeptunderstandardlaboratory
conditions (ﬁltered air, temperature 20C ± 3C, relative
humidity 30–70%, 12 h light, 12 h dark, food and water
ad libitum).
Surgical procedure
Surgerywascarriedoutunderasepticconditions.Anesthesia
was induced by intramuscular injection of 40 mg/kg Keta-
mine and 6 mg/kg Xylazine. After shaving and disinfecting
the skin, a midline incision was made, and the subcutis dis-
sected to expose the linea alba. A 35 mm 9 35 mm light-
weight hernia mesh (Optilene LP, large pores of 1 mm,
weight 36 g/m
2, thin and ﬂexible) was placed centred on the
fascia of the abdominal wall muscles. The mesh was ﬁxed
with 10 ll Histoacryl or with an absorbable suture material
ineachcorner(MonoPlusUSP3-0,singlestitch).After3,10,
30, 90, 180 and 360 days, the adhesion of the mesh to the
fascia was evaluated qualitatively, and the implantation site
examinedmacroscopicallyandhistologically. Foreach time
point, the abdominal wall of four rabbits, together with the
mesh implant was taken from the abdominal wall as a whole
and ﬁxed immediately in 4% formaldehyde. The samples
were examined macroscopically, and relevant parts embed-
ded in parafﬁn. Sections were cut on a microtome and ﬁxed
on a microscope slide. The parafﬁn was removed by Roti-
Histol
, and the samples rehydrated by isopropanol, suc-
cessively in ethanol 96, 80, 70, 50% and distilled water.
The samples were stained with hematoxylin and eosin
(H&E), embedded in xylol-carbol and covered by a glass
coverslip.
Clinical approach
Between December 2001 and January 2010, we treated
1,467 inguinofemoral hernias using the TAPP technique.
Initially, we used Vypro-2
 mesh (329) and TiMesh
 (28).
Since 2004, we have routinely used Ultrapro
 mesh
(1,110) for its convenient properties.
We ﬁxed 1,336 of these 11 9 13 cm–10 9 15 cm
meshes with only a few drops of nBCA in all four quad-
rants. As the glue was temporarily unavailable, we tacked
93 meshes with EMS alone (Endopath
, Endoscopic
Multifeed Stapler, Ethicon Endo-Surgery).
In 38 primary inguinal hernias after retropubic prosta-
tectomy or recurrenthernias after preperitoneal mesh repair,
we thought it was too risky to use only a light-weight mesh
and glue ﬁxation, according to our new concept. To dissect
the preperitoneal space was more difﬁcult, and the ﬁbro-
blastic reaction maybedelayedinthescar,thusweexpected
higher risk of mesh dislocation. We used a heavy-weight
mesh with higher ﬂexural rigidity (Prolene
) in this group
and ﬁxed it with EMS in addition to glue.
In all cases, 1 cc nBCA was sufﬁcient to ﬁx both the
unilateral and bilateral mesh. The remaining glue was often
used to adapt the peritoneal ﬂaps in order to facilitate ﬁnal
peritoneal closure with a USP 3-0 polydioxanon running
suture.
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Once the preperitoneal space is dissected, and all hernia
sacs and preperitoneal fat prolapses are reduced, the mesh
is secured to the abdominal wall. The glue application
catheter (Cavaﬁx
, Braun, Melsungen, Germany) is intro-
duced through the skin incision of T2 (pararectal right)
(Figs. 1, 2). It must be kept dry as long as possible to
prevent the nBCA from polymerizing in contact with the
humid tissue. An insulin syringe is used to facilitate
dropwise distribution of the glue (Fig. 3). Two 5 mm
graspers allow control of glue application (Fig. 4). An
experienced assistant is able to apply over 20 ‘‘drops’’ from
a 1 cc glue content. The glue is ejected from the applicator
by expelling the air. The drops of glue are placed on the
mesh, which is pressed gently against the underlying tissue,
above the symphysis pubis, above the pubic arch medial of
femoral vein, over the triangle of doom and triangle of
pain, at the level of the superior iliac spine and medial and
lateral of the inferior epigastric vessels. The peritoneal
edges are then sutured, the CO2 is evacuated, and any
trocar incision bigger than 5 mm is closed in layers.
Finally, the wounds are inﬁltrated with long-acting local
anesthetic.
During the procedure, the tip of the catheter may
gradually clog up, causing spitting or complete obstruc-
tion. However, catheter patency can be ensured by simple
measures. If one understands the behavior of the glue and
the underlying tissue, ﬁxation becomes a clear procedure:
the glued spots should be as small as possible, as tissue
in-growth in these areas is limited until the glue
degrades.
Fig. 1 The glue ﬁxation set consisting of: CavaFix
 Catheter,
Braunu ¨le
 MT puncture needle, 1 ml syringe with a 20 gauge needle
and the mesh
Fig. 2 Glue is transferred to the syringe and connected to the
catheter, which is inserted into the body by the puncture needle next
to the trocar
Fig. 3 Spot-wise application of n-butyl cyanoacrylate (nBCA) via
syringe by second surgeon
Fig. 4 The catheter is held by a grasper while the second surgeon
applies a spot of glue
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Experimental approach
To prove the safety and biocompatibility of nBCA, several
genotoxicity, sensitization, irritation and systemic toxicity
tests and an implantation study were carried out on His-
toacryl
 over 4 or 12 weeks according to ISO 10993
requirements for internal use. The Histoacryl
 extracts
were non-mutagenic and non-irritating with no evidence of
systemic toxicity, and passed all the tests prescribed by ISO
10993. Additionally, the implanted material showed good
local tolerance with only slight neo-vascularisation and
degradation, and no cell or tissue degeneration.
Furthermore, a long-term implantation study with ﬁxed
meshes was conducted in rabbits over a period of 360 days.
All animals survived until the end of the study. All skin
incisions showed a normal healing process. At each time
point, four animals were investigated in the Histoacryl

group and four in the MonoPlus
 group. Macroscopic and
microscopic analysis showed similar results for both
groups, thus only results for Histoacryl
 are presented here
in detail. All meshes were found in the implantation site,
only one in the Histoacryl
 group was dislocated by a few
centimeters. All meshes adhered to the abdominal wall at
every time point. This shows the effectiveness of the ﬁx-
ation method. The histological analysis at different time
points yielded the following results:
3 and 10 days postoperatively
The meshes were attached to the muscles without visible
tissue reaction. After 10 days, they were covered with
yellowish tissue by up to 5–50%. No difference could be
seen between implants ﬁxed by glue or suture.
As expected at this stage of wound healing, histological
images revealed a slight-to-moderate inﬂammation. Dif-
fuse inﬁltration of mixed inﬂammatory cells (granulocytes,
lymphocytes and macrophages) and a multifocal vacuolar
cavernous ﬁbrinous ﬁbroblastic tissue reaction were iden-
tiﬁed, including a slight to medium grade leucocytostasis.
After 10 days, multinuclear giant cells emerged sporadi-
cally as well as slight-to-moderate formation of directed
vascularized ﬁbroangioblastic connective tissue.
30 days postoperatively
In all animals, the mesh was attached to the fascia and
completely integrated into the connective tissue. Histology
showed slight-to-moderate diffuse inﬁltration of inﬂamma-
tory cells (lymphocytes and macrophages, few granulo-
cytes). Basophilic or eosinophilic material was enclosed,
reﬂectingaslight-to-moderatetissuereactionandformation.
Partialmultinucleargiantcellswereobserved.Nodifference
was found, either quantitatively or qualitatively, between
suture and Histoacryl
. No signs of decomposition or
resorption of the glue were detectable (Fig. 5).
180 days postoperatively
All meshes had adhered superﬁcially to the muscle tissue.
In the area of the mesh, a very slight formation of ﬁbrous
and collagenous connective tissue with low nucleated cell
counts and a slight inﬁltration of inﬂammatory cells
(mostly lymphocytes and few giant cells) were detected.
Tissue adhesive was not visible. The changes were mac-
roscopically and histologically equivalent with both suture
and Histoacryl
.
360 days post-operatively
Few variable alterations and a slight formation of white
opaque tissue with complete attachment to the sample were
observed. All samples adhered superﬁcially to the muscle
tissue. The surface of the meshes was covered extensively
or completely with white opaque tissue.
Histology showed a slight formation of non-cellular
ﬁbrous connective tissue and slight inﬁltration of inﬂam-
matory cells, including mononuclear cells (lymphocytes,
plasma cells, macrophages) and focal accumulation of
multinuclear giant cells. The glue was detected as sporadic
basophilic material in phagocytosis. No difference was
found, either quantitatively or qualitatively, between suture
and Histoacryl
 (Fig. 6, Table 1).
Clinical approach
Between December 2001 and January 2010, 1,467 TAPP
repairs were performed. In 1,336 cases, the meshes were
ﬁxed with Glubran-2 only, and 131 meshes either stapled
with EMS or stapled in combination with glue.
In both unilateral and bilateral repairs, 1 cc nBCA glue
or less was sufﬁcient to ﬁx the mesh in all cases. During
our learning curve, we grew conﬁdent and used less glue
drops on the mesh and used the rest to adapt the peritoneal
ﬂaps before ﬁnal closure with a USP 3-0 polydioxanon
running suture.
Over 98.5% of the patients were discharged on the
following day. The remaining patients stayed longer either
for social indications or prostatic pathology, but never for
reasons related to the procedure.
Twotothreedaysafterpatientdischarge,aﬁrsttelephonic
feedbackwasobtainedfrom100%ofpatients.Tendaysafter
surgery, 99% of the patients had been examined by the
operating surgeon; 5–6 weeks postoperatively, 97% of all
the patients had had either a clinical control by the operating
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in the absence of any symptoms or complaints.
Postoperative pain
The typical minor discomfort at the operation site in the
ﬁrst postoperative days has nearly disappeared since we
started to use glue ﬁxation.
Years before abandoning stapled mesh ﬁxation, we
started to close the peritoneal incision by running suture
instead of stapling it. Then, the only temporary complaint
concerned the T1 and T2 trocar wounds (10–12 mm). The
use of a smaller T2 trocar (3 instead of 12 mm) caused
another major improvement in postoperative pain
perception.
In the postoperative follow-up, we recorded VAS
(0–10) scores to improve pain management in all patients.
But our VAS records are not complete (especially for the
historical stapled control group) and pain reduction was
due to different factors. Thus, we do not use these as
evidence.
Handling
The most valuable property of cyanoacrylate is that it
polymerizes within seconds to form a strong tissue bond. In
contrast, ﬁbrin-based glues take much more time (ca. 60 s)
to set, and provide often only a weak bond that must be
reinforced by spraying over the surface of the mesh. The
viscosity of the glue is only slightly greater than that of
Fig. 5 Histoacryl
 ﬁxed
meshes after 30 days: mesh
residues (down arrows), glue
under phagocytosis (square)
medium grade formation of
connective tissue (triangles) and
diffuse slight inﬁltration of
lymphocytes and macrophages
(upright open arrows), slight
presence of giant cells (upright
ﬁlled arrows)
Fig. 6 Histoacryl
 ﬁxed
meshes after 360 days: mesh
residue (up arrows), slight
formation of ﬁbrous connective
tissue consisting of collagen
ﬁbers and few cells (triangles),
giant cells (up open arrow),
isolated chunky slightly
basophilic amorphous particles
under phagocytosis (probably
residue of glue, square)
Table 1 Overview over
histological details for the
Histoacryl
 ﬁxed implants
during implantation
a
a Only Histoacryl
 ﬁxation
shown; similar results for
ﬁxation with MonoPlus

b - not detected; o very slight/
sporadic; ? slight;
?? moderate
3 days 10 days 30 days 90 days 180 days 360 days
Animals 4 4444 4
Mesh ﬁxed 100% 100% 100% 100% 100% 100%
Mesh covered with tissue 0% 21% 89% 100% 100% 100%
Lymphocytes ?
b ?/? ? ??? o
Macrophages ?? /? ? ??- o
Granulocytes ?? o (1/4) o (1/4) --
Giant cells - oo?? o
Phagocytosis - --?- ?
Granulation tissue -? ? ? /?? ?/?? ? ?
Glue detected ?? ? o (2/4) - o (4/4)
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123water. Therefore, it must be distributed cautiously, using a
grasper.
Complications
During the 98 months of using this technique, we did not
observe, either intraoperatively or postoperatively, any
adverse reaction that could be directly or even indirectly
related to its use. The infection rate of both mesh and trocar
wounds was 0.0%.
Recurrence
In a long-term follow up of a large patient collective, it is
difﬁcult to determine exactly the true recurrence rate. We
are aware of eight patients with ten recurrences (0.7%).
Seven patients with eight hernias were explored laparo-
scopically at our institution and repaired by TAPP. There
were three patients in the stapled group (n = 131) with
three true recurrences (2.3%) and four patients in the glue
group (n = 1,336) with ﬁve recurrences (0.37%). The ﬁve
recurrences in the glue group (inguinal swelling) were two
true herniations due to mesh displacement and three pre-
peritoneal fat-prolapses/missed funicular lipomas under the
correctly lying mesh.
Cost
Signiﬁcant cost reduction is another positive aspect of
using glue. The price of 1 cc glue and the application set is
2.5 times lower than that of a tacking device.
Patient satisfaction
Patient outcomes in the ﬁrst 18 months convinced us to
stop using staple ﬁxation in the daily routine and reserve it,
in combination with glue, for difﬁcult recurrences, reo-
perations after mesh implantation in the preperitoneal
space or after radical prostatectomy.
Accidental spills
Especially when the application catheter becomes
obstructed by the polymerizing glue, accidental spills of
glue drops may occur (higher ﬂow resistance at the tip and
spitting). As the glue does not stick for several seconds, it
can be peeled off the underlying tissue; care is indicated
when removing glue from the intestinal serosa.
Additional observations
Fogging: occasionally in the past, the endoscope fogged up
at the time of peritoneal closure. By pulling the endoscope
back into the trocar tube the fog disappeared in seconds.
This was probably due to the temperature difference
resulting from the exothermic reaction in the glue poly-
merization. Curiously, this effect has disappeared in recent
years.
Sticky instruments
Should the glue come into contact with surgical instru-
ments or other materials, it can be removed mechanically
or with acetone.
Variable efﬁcacy of glue on different tissues and different
meshes
The glue is best suited to fatty tissues and least suited to
pubic bone. The three-dimensional structure of different
mesh types seems to inﬂuence the bond quality. Attempting
to ﬁx two overlapping meshes to the underlying tissue in
the midline is a frustrating exercise. Therefore we ﬁx the
most medial part of the ﬁrst mesh, and the second mesh at
the level where the overlap begins.
Discussion
The extended toxicological and implantation studies
prove the good local tolerance and biocompatibility of
Histoacryl
. This is additionally supported by the long-
term implantation of meshes ﬁxed with Histoacryl
 in
comparison to absorbable suture material. For both ﬁxa-
tion methods, formation of granulation and connective
tissue shows that the implant is well tolerated. Histo-
acryl
 seems to be absorbed almost completely after
360 days.
However, Fortelny et al. [29] do not corroborate our
ﬁndings in a study on the use of Glubran-2
 in Ti-Mesh
ﬁxation in 20 rats. This deserves some comments.
– They found glue residues in all samples. But the longest
follow-up was 3 months. This shows only that the
degradation of the glue takes longer than 3 months.
– Regarding tensile strength, they noted less resistance to
tensile forces in the glued areas than in the adjacent
areas. But this is normal since the glued areas have
limited in-growth of scar tissue until the glue is fully
degraded. The moral of the story is to apply the glue
spot-wise.
– In their experiment, they used too much glue per square
centimeter, i.e., 0.3 ml Glubran-2
 to ﬁx 4 cm
2 mesh.
In contrast, we used exactly 4 9 10 ll Histoacryl
,
i.e., 4 ll/cm
2 compared with 75 ll/cm
2 in their study.
In the case of bilateral repair, we use 1.0 ml glue for
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2 of mesh, i.e., max. 4 ll/cm
2.Obviously, 75 ll/
cm
2 glue forms a thick and compact layer, making the
mesh too rigid, and will deﬁnitely inhibit the in-growth
of ﬁbroblasts. This explains the non-vascularization of
the mesh very well.
– Furthermore, they found multiple micro-abscedations
in all samples. But, in our series, we did not observe—
experimentally or clinically—a single case of mesh or
wound infection in any animal or in any patient since
1992 when we started to use the TAPP technique, or
since 2001 when we started to use glue.
Clinical evaluation
It is difﬁcult, if not impossible, to determine the real impact
of only one among a complex of factors (e.g., prosthetic
material, suture closure of peritoneum, monopolar coagu-
lation, etc.) in terms of patient outcomes. We have expe-
rienced higher patient satisfaction since using glue ﬁxation.
To demonstrate reduced postoperative pain expressed in
VAS scores, less analgesics or shortened hospital stay,
studies would have to be carried out on smaller patient
collectives, in limited time frames, and with a constant
surgical team performing a standardized procedure. The
higher patient satisfaction in our experience may be due to
one or all of the following factors: advanced learning
curve, better tissue dissection, consequent parietalization,
bigger meshes, light-weight meshes, avoidance of pene-
trating mesh ﬁxation, peritoneal closure with running
instead of tacking suture, prudent use of monopolar cau-
tery, inﬁltration of trocar wounds with long acting local
anesthetic, awareness of chronic pain, better information,
preparation and motivation of the patient.
The overall patient satisfaction we recorded is supported
by similar ﬁndings of randomized controlled trials reported
by Helbling [30], Testini [31] or Nowobilski [32]. Very
low pain levels, shorter hospital stay, immediate unre-
stricted physical activity and shorter off-work period are
the best indicators.
The sporadic cases of long-term preperitoneal mesh
implantation (Figs. 7, 8) we encountered conﬁrm the
overall outcome.
General considerations
Novik et al. [33] point out that cyanoacrylate glues may
stick to surgical instruments, impairing handling during the
operation, and necessitating special chemical treatment for
cleaning and resterilization [29]. But the glue residues can
be removed mechanically or with acetone in difﬁcult cases.
There is no reason why reusable instruments should not be
sterilized normally.
Costs
– Suture ﬁxation of the mesh is the cheapest in terms of
material cost, but time consuming. The operative time
cost (ca. 15 €/min) must be included in the overall cost
of the operation. Three single sutures stabilize the
mesh, but do not prevent the lateral caudal corner from
lifting up.
– Tacking devices are the most costly, they are rapid in
application, but may cause injury and pain, and are thus
not really suitable to close the peritoneal gap.
– Fibrin glues are expensive, they are slow in application,
and provide a weak and frail bond.
– n-butyl cyanoacrylate glue is cheaper than tacking
devices or ﬁbrin glues, is fast acting and provides a
strong bond; it is faster and stronger than ﬁbrin and less
painful than sutures and tacks.
Fig. 7 Ultrapro
 mesh glue ﬁxation after 1 year
Fig. 8 Ultrapro
 mesh glue ﬁxation after 6 years
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In extended preclinical and clinical studies, n-butyl cya-
noacrylate has been shown to be safe for both external and
internal applications if some elementary rules are observed.
The properties of this synthetic glue make it a very
attractive alternative to other methods to ﬁx the prosthetic
meshes in laparoscopic hernia repair if it is used spot-wise
and sparingly. We consider 6–8 drops of cyanoacrylate
glue sufﬁcient to ﬁx a mesh of 15 9 10 cm. This amount
does not impair the necessary host tissue in-growth until its
complete degradation. Its positive cost-beneﬁt ratio could
make it a ﬁrst choice for this indication.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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